10-Q: USANA Reports Q3 Loss Amid Tax Hike & Direct Selling Decline

USANA Health Sciences reported a net loss of $6.5 million in Q3 2025, primarily due to a significantly higher effective tax rate and a decline in its core direct selling segment, despite revenue growth from the Hiya acquisition.

Summary

• Net sales for Q3 2025 increased 6.7% to $213.7 million, up from $200.2 million in Q3 2024.
• Net loss attributable to USANA for Q3 2025 was $6.5 million, a significant decline from net earnings of $10.6 million in Q3 2024.
• Diluted loss per common share was $(0.36) for Q3 2025, compared to diluted earnings of $0.56 in Q3 2024.
• For the nine months ended September 27, 2025, net sales increased 9.1% to $699.1 million, up from $640.9 million in the prior-year period.
• Net earnings attributable to USANA for the nine months ended September 27, 2025, were $12.5 million, down from $37.6 million in the prior-year period.
• Diluted earnings per common share for the nine months were $0.67, down from $1.96 in the prior-year period.
• The effective tax rate for the nine months ended September 27, 2025, increased to 65.0% from 43.0% in the comparable prior-year period, resulting in an incremental $7.6 million tax expense in Q3.
• The increase in consolidated net sales was primarily due to the inclusion of Hiya direct-to-consumer segment sales of $30.8 million in Q3 and $101.9 million for the nine months.
• Direct selling segment net sales declined 8.7% in Q3 and 6.8% for the nine months, primarily due to a 14.2% decrease in active Customers year-over-year.
• Active Customers in the direct selling segment decreased by 14.2% year-over-year to 388,000 as of September 27, 2025.
• Hiya direct-to-consumer segment had approximately 193,400 active Monthly Subscribers as of September 27, 2025.
• Gross profit decreased to 77.2% of net sales in Q3 2025 from 80.4% in Q3 2024, largely attributed to the lower gross margins of the Hiya segment.
• Selling, general and administrative expenses increased by $24.7 million in Q3 2025, or 960 basis points relative to net sales, partly due to Hiya's higher marketing spend, amortization costs, and increased event costs for the Global Convention.
• The company expects to incur an estimated one-time charge of $4.7 million in Q4 2025 for a global cost realignment and rightsizing process.

Sentiment

Score: 3

Explanation: The company reported a net loss for the quarter and a substantial drop in nine-month earnings and EPS, primarily due to a significantly higher effective tax rate and underperformance in its core direct selling segment, marked by declining active customers and lower Brand Partner productivity. While the Hiya acquisition boosted top-line revenue, its lower margins and associated amortization costs negatively impacted overall profitability. The planned cost realignment in Q4 2025 indicates ongoing operational challenges.

Positives

• Consolidated net sales increased 6.7% in Q3 2025 to $213.7 million and 9.1% for the nine months to $699.1 million, primarily driven by the Hiya acquisition.
• The Hiya direct-to-consumer segment contributed $30.8 million in net sales for Q3 2025 and $101.9 million for the nine months, successfully diversifying the business into a new channel.
• The 'other' category (Rise Bar Wellness, Oola Global) saw a significant net sales increase of 299.0% ($5.2 million) in Q3 2025.
• Direct selling gross margin, excluding the impact of the 'other' category, improved 50 basis points from the prior-year quarter due to cost attribution changes, modest price increases, and favorable currency exchange rates.
• The company maintains sufficient liquidity through operating cash flow and its line of credit, with no material restrictions on fund transfers among international markets (except for China's delayed remittances).
• The Credit Agreement does not include any restrictions on the payment of cash dividends or share repurchases.

Negatives

• Net loss attributable to USANA for Q3 2025 was $6.5 million, compared to net earnings of $10.6 million in Q3 2024.
• Diluted loss per share was $(0.36) in Q3 2025, down from $0.56 in Q3 2024.
• Net earnings attributable to USANA for the nine months ended September 27, 2025, decreased significantly to $12.5 million from $37.6 million in the prior-year period.
• Diluted EPS for the nine months decreased to $0.67 from $1.96 in the prior-year period.
• The effective tax rate for the nine months increased substantially to 65.0% from 43.0% in the prior-year period, resulting in an incremental $7.6 million increase in income taxes in Q3.
• Direct selling segment net sales declined 8.7% in Q3 and 6.8% for the nine months, primarily due to a 14.2% decrease in active Customers year-over-year.
• Brand Partner productivity was softer than expected during the rollout of the enhanced Brand Partner compensation plan, leading to a more pronounced slowdown than anticipated.
• Gross profit margin decreased to 77.2% in Q3 2025 from 80.4% in Q3 2024, largely due to the lower gross margins of the acquired Hiya segment.
• Selling, general and administrative expenses increased significantly by $24.7 million in Q3 2025, impacting overall profitability.
• Interest income decreased due to deploying cash reserves for the Hiya acquisition.
• Cash and cash equivalents decreased to $145.3 million from $181.8 million at December 28, 2024.
• Cash flow provided by operating activities decreased to $25.7 million for the nine months from $55.2 million in the prior-year period.
• The company expects a one-time charge of $4.7 million in Q4 2025 for cost realignment, indicating ongoing operational challenges.

Risks

• Dependence upon the direct selling business model and the activities of independent Brand Partners to grow the direct selling business.
• Dependence on acquired direct-to-consumer businesses, Hiya and Rise, to grow the business in channels outside of direct selling.
• Ability to invest in R&D, innovate, produce new products, and increase the cadence of releasing new products.
• Extensive regulation of the direct selling business model and uncertainties relating to the interpretation and enforcement of applicable laws governing direct selling and anti-pyramiding in the United States, China, and other markets.
• Risks related to operating the direct selling business in China through BabyCare Holdings, Ltd., including general operating risks, direct selling specific risks, BabyCare's business model, data privacy and security laws, and changes in the Chinese economy, marketplace, or consumer environment.
• Export control and trade sanctions laws and regulations which could impair the ability to compete in international markets or subject the company to liability.
• The Brand Partner compensation plan, or changes to it, may be viewed negatively by some Brand Partners, could fail to achieve desired objectives, and could negatively impact the direct selling business.
• Product liability claims, litigation, or other liability associated with products or their manufacturing by the company or third parties.
• Challenges associated with planned expansion into new international markets, delays in commencement of sales or product offerings, delays in compliance with local marketing or other regulatory requirements, or changes in target markets.
• Macroeconomic conditions and other factors, including inflationary pressures, slower economic growth or recession, general conditions affecting consumer spending or discretionary income, or disruptions to the supply chain.
• Political events, natural disasters, pandemics, epidemics or other health crises, or other events that may negatively affect economic conditions, consumer spending, or consumer behavior.
• Changes in the legal and regulatory environment including environmental, health and safety regulations, data security and privacy, trade policies, trade disputes, and tariffs, the impact of customs, duties, taxation, and transfer pricing regulations, as well as regulations governing distinctions between and responsibilities to employees and independent contractors.
• Geo-political tensions or conflicts, including impacts from the conflicts involving Russia and Ukraine, and Israel and Palestine, deterioration in foreign relations, as well as disputes or tensions among other countries.
• Volatile fluctuation in the value of foreign currencies against the U.S. dollar.
• Noncompliance by the company or its Brand Partners with any data privacy or security laws or any security breach by the company or a third party involving the misappropriation, loss, destruction, or unauthorized use or disclosure of confidential information.
• Shortages of raw materials, disruptions in the business of contract manufacturers, significant price increases of key raw materials, and other disruptions to the supply chain.
• Continued compliance with debt covenants in the credit facility agreement, specifically the rolling four-quarter consolidated EBITDA and consolidated funded debt to consolidated EBITDA ratio.
• Litigation, tax, and legal compliance risk and costs, especially if materially different from expected or accrued amounts.
• Information technology system failures, data security breaches, data security and privacy compliance, network disruptions, and cybersecurity attacks.
• Acquisition, divestiture, and investment-related risks, including those associated with the acquisition of Hiya, Rise, or other past or future acquisitions.
• Human capital risks associated with the business, including inability to attract or retain Brand Partner leaders or loss of key management personnel or employees.
• Ability to adequately protect and enforce intellectual property and proprietary technology.
• Ability to utilize or develop artificial intelligence technology effectively.
• Continuing volatility in the company's stock price and resulting market capitalization or a significant reduction in projected cash flows could result in a non-cash impairment charge for goodwill or indefinite-lived intangible assets in a future period.

Future Outlook

The company's commercial team will prioritize in-person meetings with Brand Partners in Q4 2025 and into next year, focusing on training and education to ensure recent product launches and compensation plan enhancements are successful and fully leveraged. An estimated one-time charge of $4.7 million is expected in Q4 2025 for a comprehensive global cost realignment and rightsizing process. The company believes its current liquidity is adequate to meet cash requirements and sustain operations for the foreseeable future. Hiya's subscription model is expected to provide a steady, predictable income stream and foster stronger customer relationships, leading to retention and loyalty. Hiya's controls and processes will be fully integrated into the assessment of internal control over financial reporting by the end of 2025.

Management Comments

• "Direct selling segment net sales were below expectations, primarily due to softer-than-expected Brand Partner productivity during the rollout of our enhanced Brand Partner compensation plan, which began during the third quarter."
• "While we expected a slowdown during this transition, it was more pronounced than anticipated."
• "Our commercial team will remain actively engaged in prioritizing in-person meetings with our Brand Partners in the fourth quarter and into next year, with a focus on training and education, to ensure that recent product launches and compensation plan enhancements are successful and fully leveraged by our global active Brand Partners."
• "Maintaining a capital structure that emphasizes sufficient liquidity and adaptability in the prevailing economic climate is our top priority."
• "We actively assess potential acquisition opportunities and investments in complementary ventures."
• "We continuously aim to preserve ample liquidity and ensure business continuity amid uncertainties, we also explore initiatives such as stock repurchases."

Industry Context

The direct selling industry faces challenges in attracting and retaining customers, as evidenced by USANA's 14.2% decline in active direct selling customers. The acquisition of Hiya Health Products and its direct-to-consumer subscription model reflects a broader industry trend towards diversifying sales channels beyond traditional direct selling, especially into e-commerce and subscription-based models for predictable revenue streams and customer data insights. The significant growth in the 'other' category (Rise Bar Wellness, Oola Global) suggests a market appetite for specialized health and wellness products and personal development frameworks, indicating potential for growth in niche segments. The company's focus on 'modernizing' its Brand Partner compensation plan indicates an effort to adapt to evolving competitive landscapes and attract/retain distributors in the direct selling space.

Comparison to Industry Standards

• NA

Corporate Governance

Legal Proceedings

• The company is involved in various lawsuits, claims, and other legal matters that arise in the ordinary course of business, including matters involving products, intellectual property, supplier relationships, distributors, competitor relationships, and employees.
• Management does not currently believe that any of these matters, individually or in the aggregate, will have a material adverse effect on the company's financial condition, liquidity, or results of operations.
• It is reasonably possible that a change in the contingencies could result in a change in the amount recorded by the company in the future.

Stakeholder Impact

• Shareholders: Negative impact due to net loss, significant decline in EPS, and increased tax rate. Potential dilution if future equity financing is pursued. Share repurchase plan remains active, which could provide some support.
• Brand Partners: Negative impact due to 'softer-than-expected Brand Partner productivity' and a 14.2% decline in active Brand Partners. The enhanced compensation plan rollout caused a slowdown, requiring increased training and education efforts.
• Customers: Hiya's subscription model aims to foster stronger relationships and retention for direct-to-consumer customers. Direct selling customers declined.
• Employees: Potential negative impact from the 'comprehensive process to align all costs throughout the business globally' and 'rightsizing process' expected to incur a one-time charge in Q4 2025, which could imply layoffs or restructuring.
• Creditors: The company entered into a new credit agreement with specific covenants (EBITDA, debt-to-EBITDA ratio) that must be maintained.

Next Steps

• Commercial team to prioritize in-person meetings with Brand Partners in Q4 2025 and into next year for training and education on product launches and compensation plan enhancements.
• Incur an estimated one-time charge of $4.7 million in Q4 2025 for a comprehensive cost realignment and rightsizing process.
• Integrate Hiya's controls and processes into the assessment of the effectiveness of internal control over financial reporting by the end of 2025.
• Continue to evaluate the impact of new accounting pronouncements (ASU 2023-09, ASU 2024-03, ASU 2025-06) on consolidated financial statements.

Key Dates

Recommendation

The company's core direct selling business is struggling, evidenced by a 14.2% decline in active customers and 'softer-than-expected Brand Partner productivity.' While the Hiya acquisition boosted top-line revenue, it introduced lower gross margins and significant amortization costs, contributing to a net loss in Q3 and a substantial drop in nine-month earnings. The effective tax rate surged to an unsustainable 65%, severely impacting profitability. The planned $4.7 million cost realignment charge in Q4 suggests ongoing operational inefficiencies. These factors, combined with declining cash flow from operations and a challenging macroeconomic environment, indicate significant headwinds and a deteriorating financial performance that warrants a 'sell' recommendation for seasoned investors.

Keywords

USANA Health Sciences, direct selling, nutritional supplements, personal care, skincare, Hiya Health Products, direct-to-consumer, children's health, wellness, Q3 2025 earnings, SEC filing, 10-Q, financial results, active customers, Brand Partners, income tax rate, acquisition, market risk, corporate governance, stock repurchase, China market, Asia Pacific, Americas and Europe, cost realignment